Monsanto relaxes restrictions on sharing seeds for research

  title={Monsanto relaxes restrictions on sharing seeds for research},
  author={Emily Waltz},
  journal={Nature Biotechnology},
  • E. Waltz
  • Published 13 October 2010
  • Biology
  • Nature Biotechnology
volume 28 number 10 oCTober 2010 nature biotechnology manufactured in the US by Novartis of Basel under license from Intercell of Vienna. Ken Eckels, who leads the research team at the Walter Reed pilot facility, has no doubt that biomanufacturing units springing up in publicly funded organizations provide a valuable service. The key, he says, is keeping up with regulatory protocols such as current good manufacturing practice and ensuring that the appropriate quality control and quality… 
5 Citations

Wellcome partners to make drugs for India

The passage of the JOBS legislation sends a strong and welcome signal to the authors' most promising companies that the US capital markets system is open for business, says the National Venture Capital Association.

Regulations Matter: Epistemic Monopoly, Domination, Patents, and the Public Interest

This paper argues that regulatory agencies have a responsibility to further the public interest when they determine the conditions under which new technological products may be commercialized. As a